Your browser is no longer supported. Please, upgrade your browser.
CPIX [NASD]
Cumberland Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.43 Insider Own39.10% Shs Outstand15.03M Perf Week2.32%
Market Cap40.15M Forward P/E53.00 EPS next Y0.05 Insider Trans0.00% Shs Float8.54M Perf Month-16.40%
Income-6.50M PEG- EPS next Q-0.07 Inst Own26.20% Short Float1.25% Perf Quarter-19.94%
Sales37.40M P/S1.07 EPS this Y27.80% Inst Trans-0.10% Short Ratio1.94 Perf Half Y-8.93%
Book/sh3.13 P/B0.85 EPS next Y- ROA-3.40% Target Price- Perf Year-32.05%
Cash/sh- P/C- EPS next 5Y30.00% ROE-6.90% 52W Range2.58 - 4.06 Perf YTD-10.17%
Dividend- P/FCF7.58 EPS past 5Y-64.60% ROI-10.40% 52W High-34.65% Beta0.23
Dividend %- Quick Ratio1.50 Sales past 5Y2.20% Gross Margin77.40% 52W Low2.71% ATR0.09
Employees90 Current Ratio1.90 Sales Q/Q10.80% Oper. Margin-16.90% RSI (14)34.11 Volatility2.07% 2.96%
OptionableNo Debt/Eq0.00 EPS Q/Q47.00% Profit Margin-8.90% Rel Volume0.42 Prev Close2.66
ShortableYes LT Debt/Eq0.32 EarningsMay 11 AMC Payout- Avg Volume55.00K Price2.65
Recom- SMA20-7.65% SMA50-13.83% SMA200-15.85% Volume24,656 Change-0.38%
Nov-12-12Reiterated UBS Neutral $6.50 → $5
Feb-01-11Reiterated UBS Neutral $8 → $6.50
Dec-16-10Downgrade UBS Buy → Neutral $10 → $8
Aug-17-10Reiterated UBS Buy $11 → $10
Aug-17-10Reiterated Morgan Joseph Buy $15 → $10
Aug-17-10Downgrade Jefferies Buy → Hold $13 → $5.50
May-14-10Reiterated Morgan Joseph Buy $21 → $15
May-04-21 04:05PM  
Mar-09-21 06:45PM  
04:26PM  
04:05PM  
01:30PM  
Mar-08-21 10:08AM  
Mar-02-21 04:05PM  
Feb-17-21 12:59AM  
Nov-27-20 05:22PM  
Nov-17-20 11:05AM  
Nov-10-20 05:45PM  
05:21PM  
04:05PM  
02:30PM  
Nov-09-20 10:28AM  
Nov-03-20 04:05PM  
12:30PM  
Sep-03-20 08:47AM  
Aug-18-20 09:35AM  
Aug-11-20 05:35PM  
05:20PM  
04:05PM  
Aug-10-20 11:04AM  
Aug-04-20 04:05PM  
Jul-20-20 08:35AM  
Jun-15-20 12:00PM  
Jun-03-20 11:09AM  
May-27-20 06:00PM  
May-26-20 04:05PM  
May-22-20 07:30AM  
May-20-20 06:15PM  
04:05PM  
02:30PM  
May-15-20 04:40PM  
May-11-20 04:10PM  
May-05-20 12:30PM  
Apr-28-20 09:35AM  
Apr-17-20 08:37AM  
Apr-16-20 08:37AM  
Apr-07-20 05:00PM  
Apr-02-20 01:23PM  
Mar-31-20 05:00PM  
12:43PM  
Mar-23-20 05:00PM  
Mar-18-20 05:35PM  
04:05PM  
02:30PM  
Mar-17-20 09:35AM  
Mar-11-20 12:30PM  
Mar-06-20 04:35PM  
Mar-04-20 09:35AM  
Jan-07-20 04:05PM  
Jan-06-20 02:25PM  
Jan-02-20 09:35AM  
Dec-22-19 06:43PM  
Dec-04-19 09:21AM  
Dec-02-19 08:00AM  
Nov-25-19 09:35AM  
Nov-12-19 04:05PM  
Nov-05-19 05:45PM  
11:24AM  
10:32AM  
09:35AM  
Nov-02-19 10:30AM  
Oct-30-19 05:45PM  
Oct-24-19 05:45PM  
Oct-16-19 05:50PM  
Oct-15-19 09:35AM  
Oct-10-19 05:45PM  
Oct-04-19 05:45PM  
Sep-26-19 11:01AM  
Sep-25-19 12:25PM  
Sep-24-19 09:35AM  
Sep-19-19 08:01AM  
Sep-13-19 09:25AM  
Sep-12-19 10:26AM  
09:00AM  
Sep-10-19 11:46AM  
Sep-09-19 09:50AM  
Sep-06-19 10:33AM  
08:45AM  
Sep-05-19 09:38AM  
Aug-21-19 08:45AM  
Aug-14-19 05:25PM  
04:05PM  
07:24AM  
Aug-07-19 01:45PM  
Aug-06-19 10:30AM  
Jul-18-19 02:33PM  
Jul-12-19 02:30PM  
Jul-05-19 10:09AM  
Jun-26-19 08:32AM  
Jun-25-19 05:50PM  
09:28AM  
Jun-19-19 05:50PM  
08:25AM  
Jun-18-19 10:25AM  
Jun-04-19 10:08AM  
09:30AM  
08:39AM  
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Galante Joseph CDirectorAug 26Buy3.2922574024,892Aug 28 05:15 PM
Galante Joseph CDirectorAug 21Buy3.353751,25624,667Aug 28 05:15 PM
Galante Joseph CDirectorAug 14Buy3.443751,29024,292Aug 28 05:15 PM
Galante Joseph CDirectorAug 07Buy3.423751,28223,917Aug 28 05:15 PM
Galante Joseph CDirectorJul 31Buy3.263751,22223,542Aug 28 05:15 PM
Galante Joseph CDirectorJul 24Buy3.333751,24923,167Aug 28 05:15 PM
Galante Joseph CDirectorJul 17Buy3.293751,23422,792Aug 28 05:15 PM
Galante Joseph CDirectorJul 10Buy3.313751,24122,417Aug 28 05:15 PM
Galante Joseph CDirectorJul 02Buy3.343001,00222,042Aug 28 05:15 PM
Galante Joseph CDirectorJun 26Buy3.373751,26421,742Aug 28 05:15 PM
Galante Joseph CDirectorJun 19Buy3.413751,27921,367Aug 28 05:15 PM
Galante Joseph CDirectorJun 12Buy3.3722575820,992Aug 28 05:15 PM
Galante Joseph CDirectorJun 09Buy3.487526120,767Jun 12 05:32 PM
Galante Joseph CDirectorJun 08Buy3.547526620,692Jun 12 05:32 PM
Galante Joseph CDirectorJun 05Buy3.447525820,617Jun 12 05:32 PM
Galante Joseph CDirectorJun 04Buy3.317524820,542Jun 12 05:32 PM
Galante Joseph CDirectorJun 03Buy3.297524720,467Jun 12 05:32 PM
Galante Joseph CDirectorJun 02Buy3.357525120,392Jun 12 05:32 PM
Galante Joseph CDirectorJun 01Buy3.457525920,317Jun 12 05:32 PM
Galante Joseph CDirectorMay 29Buy3.357525120,242Jun 12 05:32 PM
Galante Joseph CDirectorMay 28Buy3.347525020,167Jun 12 05:32 PM
Galante Joseph CDirectorMay 27Buy3.497526220,092Jun 12 05:32 PM
Galante Joseph CDirectorMay 26Buy3.597526920,017Jun 12 05:32 PM
Galante Joseph CDirectorMay 22Buy3.617527119,942Jun 12 05:32 PM
Galante Joseph CDirectorMay 21Buy3.687527619,867Jun 12 05:32 PM
Galante Joseph CDirectorMay 20Buy3.777528319,792Jun 12 05:32 PM
Galante Joseph CDirectorMay 19Buy3.787528419,717Jun 12 05:32 PM
Galante Joseph CDirectorMay 18Buy3.827528619,642Jun 12 05:32 PM
Galante Joseph CDirectorMay 15Buy3.767528219,567Jun 12 05:32 PM
Galante Joseph CDirectorMay 14Buy3.817528619,492Jun 12 05:32 PM
Galante Joseph CDirectorMay 13Buy3.9315059019,417Jun 12 05:32 PM